 |
DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics and cardiology-related medical community. DRG International’s global headquarters is based in Mountainside, New Jersey. DRG International offers various laboratory immunodiagnostic products and equipment. The focus assay types are: Enzyme Immuno (ELISA) assays | Saliva tests | Tumour marker assays | Chemiluminescencs assays | Rapidscreen assays |
|
|
Introducing the Hepcidin 25 Bioactive DRG ELISA KIT DRG is a leading developer of technology for detection of Hepcidin with 17 novel patents obtained in this area. Current diagnostic tests for iron do not provide adequate information for the diagnosis, monitorin and treatment of current iron-related diseases. DRG’s Hepcidin 25 bioactive ELISA is a breakthrough product that is at the forefront of a new wave of diagnostic tests that will lead to better diagnosis and treatment of iron metabolism disorders. |
 |
|
| Wide range of ELISA Assays Offering over 900 different ELISA assays, covering a very wide range of targets, DRG are able to offer an ELISA assay for many of the assay requirements of an immune-diagnostic or research laboratory. A fully automated Random Access Analyser for Immunoassays and Clinical Chemistry. This innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters including turbidimetric tests in one sample. The comprehensive assay menu includes routine and niche parameters. The Hybrid-XL is a small format Random Access Analyser, targeted a niche assays for routine analysis. |
||